The atherogenic index of plasma predicts long-term outcomes in patients with severe coronary artery calcification

Ben Hu1, Yuwei Wang1, Zihan Li1,2

  • 1Department of Cardiology, Division of Life Science and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230001, China.

PubMed

Insights

High atherogenic index of plasma (AIP) significantly increases adverse outcomes in patients with severe coronary artery calcification (CAC) undergoing rotational atherectomy (RA). This readily available biomarker aids in enhancing risk prediction models for better patient management.

Area of Science:

  • Cardiovascular Medicine
  • Biomarker Research
  • Machine Learning in Healthcare

Background:

  • Atherogenic index of plasma (AIP) is linked to atherosclerotic burden.
  • Prognostic value of AIP in severe coronary artery calcification (CAC) patients undergoing rotational atherectomy (RA) is not well-established.
  • Need to explore AIP's role and risk factors using machine learning.

Purpose of the Study:

  • To evaluate the association between AIP and adverse outcomes in severe CAC patients undergoing RA.
  • To identify risk factors for adverse events using explainable machine learning.

Main Methods:

  • Included 513 patients with severe CAC undergoing RA (median follow-up 40.55 months).
  • Assessed AIP tertiles, cardiovascular death, all-cause death, MI, TVR, and stroke.
  • Employed Cox regression, restricted cubic splines, Kaplan-Meier analysis, and machine learning (LASSO, Random Forest, SHAP).

Main Results:

  • Highest AIP tertile correlated with significantly increased risks of cardiovascular death (HR 2.40), all-cause death (HR 1.68), MI (HR 2.27), TVR (HR 1.74), and stroke (HR 1.92).
  • A dose-response relationship was observed between AIP and adverse outcomes.
  • Random Forest model showed strong predictive performance (AUC=0.800), with AIP identified as a key feature by SHAP analysis.

Conclusions:

  • AIP is an independent predictor of adverse outcomes in severe CAC patients undergoing RA.
  • Integrating AIP into explainable machine learning models can improve cardiovascular risk prediction.
  • AIP is a low-cost, accessible biomarker for enhanced risk stratification.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
370
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
440
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
850